These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 15924505)

  • 21. How drug-like are 'ugly' drugs: do drug-likeness metrics predict ADME behaviour in humans?
    Ritchie TJ; Macdonald SJ
    Drug Discov Today; 2014 Apr; 19(4):489-95. PubMed ID: 24462956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein binding and drug clearance.
    Rowland M
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():10-7. PubMed ID: 6705422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presystemic extraction: mechanisms and consequences.
    Greenblatt DJ
    J Clin Pharmacol; 1993 Jul; 33(7):650-6. PubMed ID: 8366190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular filtration rate measurement in cirrhotic patients with renal failure.
    Roy L; Legault L; Pomier-Layrargues G
    Clin Nephrol; 1998 Dec; 50(6):342-6. PubMed ID: 9877106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic disease and drug pharmacokinetics.
    Williams RL; Mamelok RD
    Clin Pharmacokinet; 1980; 5(6):528-47. PubMed ID: 7002418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacokinetics of nimesulide.
    Bernareggi A
    Clin Pharmacokinet; 1998 Oct; 35(4):247-74. PubMed ID: 9812177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjusting dosage of drugs in patients with kidney or liver failure].
    Krähenbühl S
    Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug therapy in impaired liver and kidney function].
    Galeazzi RL
    Schweiz Med Wochenschr; 1983 May; 113(20):726-32. PubMed ID: 6879125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.
    Neal EA; Meffin PJ; Gregory PB; Blaschke TF
    Gastroenterology; 1979 Jul; 77(1):96-102. PubMed ID: 447033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing renal function in cirrhotic patients: problems and pitfalls.
    Sherman DS; Fish DN; Teitelbaum I
    Am J Kidney Dis; 2003 Feb; 41(2):269-78. PubMed ID: 12552488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-steroidal anti-inflammatory drugs: restrictive or non-restrictive hepatic clearance?
    Verbeeck RK; Wallace SM
    Arzneimittelforschung; 1994 May; 44(5):683-5. PubMed ID: 8024649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis.
    Orlando R; Floreani M; Napoli E; Padrini R; Palatini P
    Nephron; 2000 Jan; 84(1):32-9. PubMed ID: 10644906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
    Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
    Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    Getachew H; Tadesse Y; Shibeshi W
    BMC Nephrol; 2015 Oct; 16():158. PubMed ID: 26446847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Handling of drugs by cirrhotic patients].
    Danan G; Pariente A
    Rev Prat; 1986 Sep; 36(39):2298-308. PubMed ID: 3809928
    [No Abstract]   [Full Text] [Related]  

  • 38. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis.
    Caregaro L; Menon F; Angeli P; Amodio P; Merkel C; Bortoluzzi A; Alberino F; Gatta A
    Arch Intern Med; 1994 Jan; 154(2):201-5. PubMed ID: 8285815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic drug interactions with theophylline.
    Jonkman JH; Upton RA
    Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.